Skip to main content
. 2022 Dec 7;13:1046755. doi: 10.3389/fimmu.2022.1046755

Figure 1.

Figure 1

Strategies for targeting CD8+ T cell metabolism in combination with ICIs. Using small-molecule drugs or gene interference technology to target relevant elements in the metabolic pathways in the cytoplasm (A) and mitochondria (B) of CD8+ T cells, or targeting transcription factors that regulate metabolism (B), can improve the efficacy of ICI therapy and exert a greater antitumor effect.